Surgery for the Intact Primary and Stage IV Breast Cancer…Lacking “Robust Evidence” Seema A. Khan Breast Oncology 07 May 2013 Pages: 2803 - 2805
Hepatic Artery Infusion: Still an Option? Lawrence D. Wagman Hepatobiliary Tumors 21 May 2013 Pages: 2806 - 2807
The Financial Burden of Reexcising Incompletely Excised Soft Tissue Sarcomas: A Cost Analysis Vignesh K. AlamandaGadini O. DeliscaGinger E. Holt Healthcare Policy and Outcomes 30 April 2013 Pages: 2808 - 2814
Population-Level Analysis of Pancreatic Neuroendocrine Tumors 2 cm or Less in Size Eric J. KuoRonald R. Salem Healthcare Policy and Outcomes 15 June 2013 Pages: 2815 - 2821
Prognosis in Women with Breast Cancer and Private Extra Insurance Coverage Juan J. GrauGabriel ZanonAlbert Biete Healthcare Policy and Outcomes Open access 11 June 2013 Pages: 2822 - 2827
Meta-Analysis to Determine if Surgical Resection of the Primary Tumour in the Setting of Stage IV Breast Cancer Impacts on Survival Elly HarrisMitchel BarryMalcolm R. Kell Breast Oncology 08 May 2013 Pages: 2828 - 2834
Residual Lymph Node Disease After Neoadjuvant Chemotherapy Predicts an Increased Risk of Lymphedema in Node-Positive Breast Cancer Patients Michelle C. SpechtCynthia L. MillerAlphonse G. Taghian Breast Oncology 21 May 2013 Pages: 2835 - 2841
Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers S. Shafaq MujtabaYun-Bi NiGary M. Tse Breast Oncology 29 March 2013 Pages: 2842 - 2849
A Model to Predict the Risk of Upgrade to Malignancy at Surgery in Atypical Breast Lesions Discovered on Percutaneous Biopsy Specimens Catherine UzanChafika MazouniSuzette Delaloge Breast Oncology 24 May 2013 Pages: 2850 - 2857
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Cytologically Proven Node-positive Breast Cancer at Diagnosis Seho ParkJi Min ParkByeong-Woo Park Breast Oncology 05 May 2013 Pages: 2858 - 2865
Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer? Tiffanie JonesHanmanth NebooriMeena S. Moran Breast Oncology 10 May 2013 Pages: 2866 - 2872
Cost-Effectiveness Analysis of Intraoperative Radiation Therapy for Early-Stage Breast Cancer Michael D. AlvaradoAron J. MohanElissa M. Ozanne Breast Oncology 29 June 2013 Pages: 2873 - 2880
Long-Term Outcomes Comparing Surgery to Embolization-Ablation for Treatment of Solitary HCC <7 cm Eldad ElnekaveJoseph P. ErinjeriAnne M. Covey Hepatobiliary Tumors 07 April 2013 Pages: 2881 - 2886
Financial Comparison of Laparoscopic Versus Open Hepatic Resection Using Deviation-Based Cost Modeling Robert M. CannonCharles R. ScogginsRobert C. G. Martin II Hepatobiliary Tumors 01 May 2013 Pages: 2887 - 2892
Gd-EOB-DTPA-Enhanced MRI is Better than MDCT in Decision Making of Curative Treatment for Hepatocellular Carcinoma Sun Hong YooJong Young ChoiEun Sun Jung Hepatobiliary Tumors 07 May 2013 Pages: 2893 - 2900
Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution John B. AmmoriNancy E. KemenyMichael I. D’Angelica Hepatobiliary Tumors 15 June 2013 Pages: 2901 - 2907
Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer Hae-Jung SonJi Won ParkJae Hwan Oh Colorectal Cancer 25 April 2013 Pages: 2908 - 2913
Elevation of Preoperative s-CEA Concentration in Stage IIA Colorectal Cancer Can Also Be a High Risk Factor for Stage II Patients Chan Wook KimYong Sik YoonJin Cheon Kim Colorectal Cancer 13 June 2013 Pages: 2914 - 2920
Modern Rectal Cancer Multidisciplinary Treatment: The Role of Radiation and Surgery Marco E. AllaixAlessandro Fichera Colorectal Cancer 21 April 2013 Pages: 2921 - 2928
Multivisceral Resection in Colorectal Cancer: A Systematic Review H. M. MohanM. D. EvansD. C. Winter Colorectal Cancer 11 May 2013 Pages: 2929 - 2936
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience Piotr RutkowskiAlessandro GronchiFrits van Coevorden Bone and Soft Tissue Sarcomas 13 June 2013 Pages: 2937 - 2943
Does Hürthle Cell Carcinoma of the Thyroid Have a Poorer Prognosis than Ordinary Follicular Thyroid Carcinoma? Kiminori SuginoKaori KameyamaKunihiko Ito Endocrine Tumors 26 April 2013 Pages: 2944 - 2950
Should an Involved but Functioning Recurrent Laryngeal Nerve be Shaved or Resected in a Locally Advanced Papillary Thyroid Carcinoma? Brian Hung-Hin LangChung-Yau LoKoon Yat Wan Endocrine Tumors 01 May 2013 Pages: 2951 - 2957
Multicenter Institutional Experience of Surgically Resected Thymic Epithelial Tumors (TETs): An Observational Report on Behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone) Giovenzio GenestretiLuca AmpolliniGiampaolo Gavelli Endocrine Tumors 26 May 2013 Pages: 2958 - 2963
Is Potassium Iodide Solution Necessary Before Total Thyroidectomy for Graves Disease? Myrick C. Shinall Jr.James T. BroomeCarmen C. Solorzano Endocrine Tumors 12 July 2013 Pages: 2964 - 2967
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Asian Patients: 100 Consecutive Patients in a Single Institution Melissa Ching Ching TeoGrace Hwei Ching TanKhee Chee Soo Gastrointestinal Oncology 17 March 2013 Pages: 2968 - 2974
Esophagojejunal Reconstruction After Total Gastrectomy for Gastric Cancer Using a Transorally Inserted Anvil Delivery System J. LaFeminaE. F. ViñuelaV. E. Strong Gastrointestinal Oncology 16 April 2013 Pages: 2975 - 2983
Embedded Cervical Esophagogastrostomy: A Simple and Convenient Method Using a Circular Stapler After Esophagectomy for Esophageal Carcinomas Sen WuMingyao ChenZhong Chen Gastrointestinal Oncology Open access 05 May 2013 Pages: 2984 - 2990
D2 Lymphadenectomy with Surgical Ex Vivo Dissection into Node Stations for Gastric Adenocarcinoma Can Be Performed Safely in Western Patients and Ensures Optimal Staging Benjamin SchmidtKevin K. ChangSam S. Yoon Gastrointestinal Oncology 13 June 2013 Pages: 2991 - 2999
Using Pretreatment Tumor Depth and Length to Select Esophageal Squamous Cell Carcinoma Patients for Nonoperative Treatment After Neoadjuvant Chemoradiotherapy Yin-Kai ChaoChen-Kan TsengHsien-Kun Chang Gastrointestinal Oncology 13 April 2013 Pages: 3000 - 3008
Which is the Optimal Response Criteria for Evaluating Preoperative Treatment in Esophageal Cancer: RECIST or Histology? Yukinori KurokawaTaro ShibataHaruhiko Fukuda Thoracic Oncology 17 March 2013 Pages: 3009 - 3014
EGFR and TTF-1 Gene Amplification in Surgically Resected Lung Adenocarcinomas: Clinicopathologic Significance and Effect on Response to EGFR-Tyrosine Kinase Inhibitors in Recurred Cases Jae Seok LeeHye Ryun KimHyo Sup Shim Thoracic Oncology 23 March 2013 Pages: 3015 - 3022
Outcome of Patients with Esophageal Cancer: A Nationwide Analysis Miao-Fen ChenYao-Hsu YangWen-Cheng Chen Thoracic Oncology 23 March 2013 Pages: 3023 - 3030
Assessment of Sentinel Node Concept in Esophageal Cancer Based on Lymph Node Micrometastasis Takahiko HagiharaYoshikazu UenosonoShoji Natsugoe Thoracic Oncology 13 April 2013 Pages: 3031 - 3037
Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Ravi ShridharSarah E. HoffeKenneth Meredith Thoracic Oncology 28 April 2013 Pages: 3038 - 3043
REG1A Expression Status Suggests Chemosensitivity Among Advanced Thoracic Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy Followed by Adjuvant Chemotherapy Yusuke SatoSatoru MotoyamaJun-ichi Ogawa Thoracic Oncology 05 May 2013 Pages: 3044 - 3051
Nodal Skip Metastasis is not a Predictor of Survival in Thoracic Esophageal Squamous Cell Carcinoma Zhengfei ZhuWeiwei YuXiaolong Fu Thoracic Oncology 18 May 2013 Pages: 3052 - 3058
Lung Resistance-Related Protein (LRP) Expression in Malignant Ascitic Cells as a Prognostic Marker for Advanced Ovarian Serous Carcinoma Elizabeth H. KerrPeter J. FrederickLacey R. McNally Gynecologic Oncology 24 March 2013 Pages: 3059 - 3065
Outcomes and Prognostic Factors of Post-irradiation and de novo Sarcomas of the Head and Neck: A Histologically Matched Case-Control Study Ming Sheng YeangKaijun TayN. Gopalakrishna Iyer Head and Neck Oncology 19 April 2013 Pages: 3066 - 3075
mTHPC-mediated Photodynamic Therapy of Early Stage Oral Squamous Cell Carcinoma: A Comparison to Surgical Treatment Sebastiaan A. H. J. de VisscherLieuwe J. MelchersMax J. H. Witjes Head and Neck Oncology 19 May 2013 Pages: 3076 - 3082
Thyroid Nodules with Bethesda System III Cytology: Can Ultrasonography Guide the Next Step? Hye Mi GweonEun Ju SonJeong-Ah Kim Head and Neck Oncology 23 May 2013 Pages: 3083 - 3088
Is Head and Neck Melanoma Different from Trunk and Extremity Melanomas with Respect to Sentinel Lymph Node Status and Clinical Outcome? Niloofar FadakiRui LiStanley P. L. Leong Melanomas 07 May 2013 Pages: 3089 - 3097
Outcome of Clinical Stage III Melanoma Patients with FDG-PET and Whole-Body CT Added to the Diagnostic Workup M. G. NieblingE. BastiaannetH. J. Hoekstra Melanomas 24 April 2013 Pages: 3098 - 3105
Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma David E. GyorkiJianda YuanCharlotte E. Ariyan Melanomas 17 May 2013 Pages: 3106 - 3111
Preoperative Classification of Pancreatic Cystic Neoplasms: The Clinical Significance of Diagnostic Inaccuracy Clifford S. ChoAndrew J. RussSharon M. Weber Pancreatic Tumors 18 April 2013 Pages: 3112 - 3119
Posterior Approach for Laparoscopic Pancreaticoduodenectomy to Prevent Replaced Hepatic Artery Injury Satoshi OgisoClaudius ConradBrice Gayet Pancreatic Tumors 21 June 2013 Pages: 3120 - 3120
Diagnostic Ureteroscopy Independently Correlates with Intravesical Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma Hao Lun LuoChih Hsiung KangPo Hui Chiang Urologic Oncology 10 May 2013 Pages: 3121 - 3126
Gleason 5+4 Has Worse Oncological and Pathological Outcomes Compared with Gleason 4+5: Significance of Gleason 5 Pattern Sey Kiat LimKwang Hyun KimKoon Ho Rha Urologic Oncology 18 May 2013 Pages: 3127 - 3132
Tumor Volume Adds Prognostic Value in Patients with Organ-Confined Prostate Cancer Kwang Hyun KimSey Kiat LimSung Joon Hong Urologic Oncology 30 May 2013 Pages: 3133 - 3139
XB130 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma Atsushi ShiozakiToshiyuki KosugaEigo Otsuji Translational Research and Biomarkers 18 July 2012 Pages: 3140 - 3150